亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

中國武漢遠成共創科技有限公司  

精細化工,香精香料,食品添加劑,醫藥原料及中間體等產品

搜索
新聞中心
產品分類
  • 暫無分類
聯系方式
  • 聯系人:葉飛
  • 電話:027-68886406
  • 郵件:yf@yccreate.com
  • 傳真:027-68886696-910
  • QQ:2355327137
站內搜索
 
榮譽資質
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 丙酸氯倍他索Clobetasol propionate
丙酸氯倍他索Clobetasol propionate
單價 面議對比
詢價 暫無
發貨 湖北武漢市付款后3天內
過期 長期有效
更新 2014-11-12 16:05
 
詳細信息
丙酸氯倍他索Clobetasol propionate

類 別:皮膚科用藥-糖皮質激素

其他名稱:氯倍氟美松丙醋酸,氯培他索,特美膚,蒽膚,丙酸倍氯松,丙酸氯倍他索,二丙酸氯倍他米 松,特美膚 ,丙酸氯倍米松

化學名:16β-甲基-11β-羥基-17-(1-氧代丙基)-9-氟-21-氯-孕甾-1,4-二烯-3,20-二酮; 21-Chloro-9-fluoro-11b,17-dihydroxy-16b-methylpregna-1,4-diene-3,20-d

ione 17-propionate

分子式:C25H32ClFO5

分子量:466.97

CAS 號:25122-46-7

含量 : 98.5-102%

標準級別:USP32

熔點:約196°C

比旋光度:+98 - +104°C

外觀:白色結晶性粉末

用途:1、丙酸氯倍他索為人工合成的高效局部外用糖皮質激素類藥物。


©2025 中國武漢遠成共創科技有限公司 版權所有   技術支持:化工網   訪問量:19323  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |